Correlation Between OncoCyte Corp and Evogene
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and Evogene, you can compare the effects of market volatilities on OncoCyte Corp and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Evogene.
Diversification Opportunities for OncoCyte Corp and Evogene
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between OncoCyte and Evogene is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Evogene go up and down completely randomly.
Pair Corralation between OncoCyte Corp and Evogene
Considering the 90-day investment horizon OncoCyte Corp is expected to generate 0.79 times more return on investment than Evogene. However, OncoCyte Corp is 1.26 times less risky than Evogene. It trades about 0.0 of its potential returns per unit of risk. Evogene is currently generating about -0.1 per unit of risk. If you would invest 301.00 in OncoCyte Corp on September 4, 2024 and sell it today you would lose (56.00) from holding OncoCyte Corp or give up 18.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
OncoCyte Corp vs. Evogene
Performance |
| Timeline |
| OncoCyte Corp |
| Evogene |
OncoCyte Corp and Evogene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoCyte Corp and Evogene
The main advantage of trading using opposite OncoCyte Corp and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.| OncoCyte Corp vs. Candel Therapeutics | OncoCyte Corp vs. Anebulo Pharmaceuticals | OncoCyte Corp vs. Cingulate Warrants | OncoCyte Corp vs. Unicycive Therapeutics |
| Evogene vs. Candel Therapeutics | Evogene vs. Anebulo Pharmaceuticals | Evogene vs. Cingulate Warrants | Evogene vs. Unicycive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |